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CASE REPORT
Solitary fibrous tumor of 
the nasal cavity
Gisele Alborghetti Nai1, Gabriel Cardoso Ramalho Neto2
INTRODUCTION
The solitary fibrous tumor (SFT) is a 
mesenchymal neoplasm first described by 
Klemperer and Rabin1 in 1931. It involves 
primarily the pleura, but has been descri-
bed in the urinary bladder, limbs, thorax 
and abdomen, lungs, kidneys, prostate, 
meninges, mediastinum, and head & neck.2
In the head and neck, this tumor 
may involve the orbit, salivary glands, soft 
tissues, eyelids, mouth and nose, nasopha-
rynx, retropharinx, oropharynx, and the 
thyroid gland.3,4
This study presents the fifth case of 
nasal SFT in the literature, the second in 
the Latin-American literature.
CASE REPORT
A male patient aged 54 years pre-
sented with epistaxis. Cranial computed to-
mography (CT) revealed a large expansive 
tumor in the nasal fossa (Fig. 1).
A biopsy was undertaken, but 
excessive bleeding during this procedure 
resulted in insufficient material for a diag-
nosis. Surgery was done for full removal 
of the tumor.
The macroscopic exam showed a 
well-defined, white and fibrous tumor mea-
suring 6 x 4 x 4 cm; sections demonstrated 
a large hemorrhagic infarction.
Microscopy revealed a hypocellular 
neoplasm consisting of fusiform cells within 
a dense collagen stroma; there were many 
vascular areas (Fig. 2). No mitotic activity 
was evidenced in the tumor.
Immunohistochemistry defined the 
diagnosis of SFT by demonstrating positive 
neoplastic cells for CD34 and vimentin 
markers (Fig. 3), and negative results for 
AE1/AE3 cytokeratin (epithelial marker), 
HHF35 (smooth muscle actin) and the S100 
protein (neural marker).
The patient progressed well posto-
peratively, with no recurrences one and a 
half year after surgery.
DISCUSSION
SFT is an uncommon neoplasm. 
Many terms have been used to name it, 
reflecting the initial controversies around 
its histogenesis. This tumor was first 
considered as a submesothelial1 or me-
sothelial neoplasm; it is currently defined 
as a mesenchymal tumor with findings 
reflecting myopericytic, fibroblastic and 
myofibroblastic differentiation to justify 
extrapleural cases.
The diagnosis of this tumor may be 
difficult when it is not located in the pleura, 
given the variability of its histology. Typical 
microscopic findings are: storiform growth 
pattern, fusiform cells with no atypias, al-
ternating dense cell and hypocellular areas 
and prominent branched vascularization 
similar to that of hemangiopericytomas. 
Histochemical studies diffusely express 
vimentin and CD34 protein, bcl-2 and CD99 
focally, and are negative for muscle and 
epithelial cell markers.2
The present case is typical in term 
of incidence and tumor size in adults, with 
no gender preference, at a mean age 
of 50 years, measuring from 3 to 5 cm 
lengthwise.
Nasal SFTs usually result in 
nasal obstruction, occasionally epis-
taxis, rhinorrhea, anosmia, headache, 
facial pain, and visual disorders due to 
compression of the orbit.3 Our patient 
reported epistaxis, a symptom that had 
not been described in isolation.
Based on symptoms and radio-
logical findings, the clinical differential 
diagnosis of nasal cavity STFs should 
be made with: fibrosarcoma, heman-
giopericytoma, and nasopharyngeal 
carcinoma.
In the study case, due to tumor 
hypocellularity, extensive collagen 
areas, absence of cell atypias, and the 
patient’s age, the differential diagnosis 
was made with: leiomyoma, myofibroma/
myofibromatosis, fibroma and hemangio-
pericytoma. Leiomyomas are characterized 
by fusiform cells arranged in uniform anas-
tomosing fascicles; immunohistochemically 
they express HHF35. Myofibromas/myo-
fibromatosis and fibromas may be highly 
collagenic, and express vimentin, HHF35 
and muscle-specific actin; they are CD34 
negative. Hemangiopericytomas are more 
cellular and are focally and weakly positive 
for CD34 compared to STFs.
Full surgical removal is curative in 
most cases. The possibility of major blee-
ding during resection or in biopsies - as 
occurred in our case - should be taken 
into account.
The predominantly benign nature 
of nasal and extra-pleural STFs contrasts 
with the more aggressive behavior found in 
23% of pleural tumors.3 The prognosis may 
be based on the presence or absence of 
histological findings of malignancy, such as 
significant cellularity, a mitotic index above 
4 mitoses per 10 high magnification fields, 
the presence of necrosis and cellular pleo-
morphism. These findings, however, do not 
necessarily result in a clinically malignant 
behavior. A single nasal STF case described 
in the literature manifested malignancy, 
but was resected with no relapse.4 In the 
present case, histology suggested a benign 
course for the tumor, as in fact occurred.
FINAL COMMENTS
STFs, although uncommon, should 
be remembered in the differential diagnosis 
of nasal cavity neoplasms; the definitive 
diagnosis is established by immunohisto-
chemical tests and histopathology.
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Figure 1. A - Cranial CT showing a large expansive tumor in the nasal 
fossa (arrow). B - Photomicroscopy showing a fusocellular and colla-
genic neoplasm with vascular areas (hematoxylin-eosin stained, 100x 
magnification). C - Immunohistochemistry showing positive neoplastic 
cells for the CD34 marker (400x magnification).
